{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:29Z","timestamp":1776329849150,"version":"3.50.1"},"reference-count":20,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.6002\/ect.mesot2023.o16","type":"journal-issue","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T07:09:40Z","timestamp":1708067380000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Vulpio C, Bossola M. Parathyroid nodular hyperplasia and responsiveness to drug therapy in renal secondary hyperparathyroidism: an open question. Ther Apher Dial. 2018;22(1):11-21. doi:10.1111\/1744-9987.12604","DOI":"10.1111\/1744-9987.12604"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Fukagawa M, Nakanishi S. Role of parathyroid intervention in the management of secondary hyperparathyroidism. Nephrol Dial Transplant. 2003;18 Suppl 3:iii23-26. doi:10.1093\/ndt\/gfg1006","DOI":"10.1093\/ndt\/gfg1006"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Yamamoto M, Ogata H, Mizobuchi M, et al. Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism. Clin Exp Nephrol. 2012;16(2):292-299. doi:10.1007\/s10157-011-0547-5","DOI":"10.1007\/s10157-011-0547-5"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Tominaga Y, Inaguma D, Matsuoka S, et al. Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial. 2006;10(2):198-204. doi:10.1111\/j.1744-9987.2006.00364.x","DOI":"10.1111\/j.1744-9987.2006.00364.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Fuster D, Torregrosa JV, Domenech B, et al. Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism. Nucl Med Commun. 2009;30(11):890-894. doi:10.1097\/MNM.0b013e3283305df6","DOI":"10.1097\/MNM.0b013e3283305df6"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Katoh N, Nakayama M, Shigematsu T, et al. Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism. Am J Kidney Dis. 2000;35(3):465-468. doi:10.1016\/s0272-6386(00)70199-5","DOI":"10.1016\/S0272-6386(00)70199-5"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Nishida H, Ishibashi M, Hiromatsu Y, et al. Comparison of histological findings and parathyroid scintigraphy in hemodialysis patients with secondary hyperparathyroid glands. Endocr J. 2005;52(2):223-228. doi:10.1507\/endocrj.52.223","DOI":"10.1507\/endocrj.52.223"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Vulpio C, Bossola M, De Gaetano A, et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck. 2010;32(9):1226-1235. doi:10.1002\/hed.21320","DOI":"10.1002\/hed.21320"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Custodio MR, Montenegro F, Costa AF, et al. MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients. Nephrol Dial Transplant. 2005;20(9):1898-1903. doi:10.1093\/ndt\/gfh933","DOI":"10.1093\/ndt\/gfh933"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Harach HR, Jasani B. Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal. Histopathology. 1992;21(6):513-519. doi:10.1111\/j.1365-2559.1992.tb00438.x","DOI":"10.1111\/j.1365-2559.1992.tb00438.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Pattou F, Huglo D, Proye C. Radionuclide scanning in parathyroid diseases. Br J Surg. 1998;85(12):1605-1616. doi:10.1046\/j.1365-2168.1998.00942.x","DOI":"10.1046\/j.1365-2168.1998.00942.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Caldarella C, Treglia G, Pontecorvi A, Giordano A. Diagnostic performance of planar scintigraphy using (9)(9)mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med. 2012;26(10):794-803. doi:10.1007\/s12149-012-0643-y","DOI":"10.1007\/s12149-012-0643-y"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Nichol PF, Starling JR, Mack E, Klovning JJ, Becker BN, Chen H. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg. 2002;235(5):673-678; discussion 678-680. doi:10.1097\/00000658-200205000-00009","DOI":"10.1097\/00000658-200205000-00009"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Berger MG, Pandian TK, Lyden ML, McKenzie T, Drake MT, Dy BM. Preoperative imaging in renal transplant patients with tertiary hyperparathyroidism. World J Surg. 2021;45(8):2454-2462. doi:10.1007\/s00268-021-06098-0","DOI":"10.1007\/s00268-021-06098-0"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Lewin E. Involution of the parathyroid glands after renal transplantation. Curr Opin Nephrol Hypertens. 2003;12(4):363-371. doi:10.1097\/00041552-200307000-00004","DOI":"10.1097\/00041552-200307000-00004"},{"key":"ref15","unstructured":"16. Akta\u015f A, Sayin CB, Gen\u00e7o\u011flu EA, et al. Sekonder ve tersiyer hiperparatiroidide paratiroid sintigrafisi bulgularinin kar\u015fila\u015ftirilmasi. Nucl Med Semin. 2022;8(Suppl 1):68."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Gungor O, Celik A, Kebapcilar L, et al. Incidence of thyroid dysfunction and thyroid cancer in renal transplant recipients: a single center experience. Ren Fail. 2010;32(2):167-171. doi:10.3109\/08860220903541119","DOI":"10.3109\/08860220903541119"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Heizmann O, Viehl CT, Schmid R, Muller-Brand J, Muller B, Oertli D. Impact of concomitant thyroid pathology on preoperative workup for primary hyperparathyroidism. Eur J Med Res. 2009;14(1):37-41. doi:10.1186\/2047-783x-14-1-37","DOI":"10.1186\/2047-783X-14-1-37"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Kushchayeva YS, Tella SH, Kushchayev SV, Van Nostrand D, Kulkarni K. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and (123)I for localization of rapid washout parathyroid adenomas. Osteoporos Int. 2019;30(5):1051-1057. doi:10.1007\/s00198-019-04846-6","DOI":"10.1007\/s00198-019-04846-6"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Ramonell KM, Lindeman B, Chen H, Fazendin J. Parathyroidectomy for normocalcemic tertiary hyperparathyroidism: a 19-year experience. J Surg Res. 2022;276:362-368. doi:10.1016\/j.jss.2022.02.011","DOI":"10.1016\/j.jss.2022.02.011"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T01:44:24Z","timestamp":1708307064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/1\/1\/96\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":20,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2023.o16","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}